1. Home
  2. ATYR vs LSE Comparison

ATYR vs LSE Comparison

Compare ATYR & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.88

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$4.45

Market Cap

74.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
LSE
Founded
2005
2007
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
74.4M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
ATYR
LSE
Price
$0.88
$4.45
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
2.5M
9.8K
Earning Date
03-12-2026
03-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$190,000.00
$48,335,553.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$61.61
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$3.80
52 Week High
$7.29
$14.99

Technical Indicators

Market Signals
Indicator
ATYR
LSE
Relative Strength Index (RSI) 54.93 50.02
Support Level $0.82 $4.35
Resistance Level $0.94 $4.54
Average True Range (ATR) 0.10 0.33
MACD 0.01 -0.01
Stochastic Oscillator 54.37 53.59

Price Performance

Historical Comparison
ATYR
LSE

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: